Evidence map›Paper›PMID 12588889›Full record

ArticleThe Journal of clinical investigation2003

Therapeutic efficacy of sonic hedgehog protein in experimental diabetic neuropathy.

Nigel A Calcutt, Karen L Allendoerfer, Andrew P Mizisin, Alicia Middlemas, Jason D Freshwater, Monica Burgers, Rigel Ranciato, Jean-Dominique Delcroix, Frederick R Taylor, Renee Shapiro and 6 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 91 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Epigenomic Regulation of Schwann Cell Reprogramming in Peripheral Nerve Injury.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2016
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Emerging therapy for diabetic neuropathy: cell therapy targeting vessels and nerves.Endocrine, metabolic & immune disorders drug targets · 2012
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Nigel A CalcuttDepartment of Pathology, University of California at San Diego, La Jolla, California 92093-0612, USA. ncalcutt@ucsd.edu
Karen L Allendoerfer
Andrew P Mizisin
Alicia Middlemas
Jason D Freshwater
Monica Burgers
Rigel Ranciato
Jean-Dominique Delcroix
Frederick R Taylor
Renee Shapiro
Kathy Strauch
Henryk Dudek
Thomas M Engber
Alphonse Galdes
Lee L Rubin
David R Tomlinson
Biogen (United States) · USCuris (United States) · USUniversity of California, San Diego · USUniversity of Manchester · GB

Funding

PROSAPOSIN AND PROSAPTIDES IN DIABETIC NEUROPATHYR01NS038855 · NINDS · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI CALCUTT, NIGEL A · 1999 to 2002
$789k
NINDS NIH HHS NS38855
6 · The paper itself

Abstract

Hedgehog proteins modulate development and patterning of the embryonic nervous system. As expression of desert hedgehog and the hedgehog receptor, patched-1, persist in the postnatal and adult peripheral nerves, the hedgehog pathway may have a role in maturation and maintenance of the peripheral nervous system in normal and disease states. We measured desert hedgehog expression in the peripheral nerve of maturing diabetic rats and found that diabetes caused a significant reduction in desert hedgehog mRNA. Treating diabetic rats with a sonic hedgehog-IgG fusion protein fully restored motor- and sensory-nerve conduction velocities and maintained the axonal caliber of large myelinated fibers. Diabetes-induced deficits in retrograde transport of nerve growth factor and sciatic-nerve levels of calcitonin gene-related product and neuropeptide Y were also ameliorated by treatment with the sonic hedgehog-IgG fusion protein, as was thermal hypoalgesia in the paw. These studies implicate disruption of normal hedgehog function in the etiology of diabetes-induced peripheral-nerve dysfunction and indicate that delivery of exogenous hedgehog proteins may have therapeutic potential for the treatment of diabetic neuropathy.

Indexed as

AnimalsDiabetic NeuropathiesHedgehog ProteinsHumansImmunoglobulin GMaleNeural ConductionRatsRats, WistarRecombinant Fusion ProteinsRNA, MessengerSciatic NerveTrans-ActivatorsHedgehog ProteinsImmunoglobulin GRecombinant Fusion ProteinsRNA, MessengerSHH protein, humanTrans-Activators

Identifiers

PMID12588889
PMCPMC151919
OpenAlexW2141933834

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.